Breaking News
Major Grocery Chain Issues Recall Over Salmonella Threat
40,000 bottles of eye drops across the US recalled over issues with sterility of product
Martin Armstrong: Why The World Order Will Collapse in 2032 | Gold, Oil & The US Dollar
Joel Salatin: The Real Impact of Fertilizer Shortages on Farmers | The Next Farm Crisis Starts Now
Top Tech News
High-voltage sodium home battery emerges as affordable rooftop solar solution
Peter Thiel-Funded Company Anduril to Triple the Number of Autonomous Surveillance...
China has released Origin Pilot, claimed to be the world's first open-source operating system...
ShieldAI XBAT Drone Fighters Can Give A Fighter Drone Wing to Every US Destroyer
Brain organoids, kept alive more than five years, matured like human brains
Parkinson's patient's tremors VANISH within minutes of GROUNDBREAKING treatment
Polaris injects pneumatic shifting into expedition-grade side-by-side
NEW HOMES ARE BUILT WITH THIS AND IT'S MAKING YOU SICK
S3E33: I Beat the Attorney General. No Lawyers. My Legal Team Was AI
World's largest all-electric plane completes maiden flight
New blood, computer brains and frozen heads: How billionaires 'will live forever'
Over the past year, the gap between the super-rich and the rest of us has grown wider than ever before.
But the difference between ordinary people and billionaires might be more than just money. Some high net worth individuals have been looking into extending their lives far beyond the 70 or 80 years most of us might hope for.
Peter Thiel, for example, the billionaire co-founder of PayPal, has invested in a number medical research start-ups looking extending life expectancy though his Breakout Labs fund.
One of the companies longevity obsessive Thiel has bankrolled is Ambrosia.
Ambrosia is one of three outfits looking at experimental "vampire" blood transfusions that put the blood of young people into the lens of oldies.
According to commercial finance experts ABC Finance, the cost of the trials currently ranges from £6,000 to about £215,000.